• Study on Selumetinib for Adults with Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy Poland Spain
  • Study of BI 764198 for Patients with Focal Segmental Glomerulosclerosis

    Not recruiting

    2 1
    Investigated Diseases:
    Belgium France Germany Italy Spain
  • Study of BP05 and Ranibizumab Efficacy and Safety in Patients with Wet Age-Related Macular Degeneration

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Latvia Slovakia
  • Study of brivaracetam as a treatment for childhood and juvenile absence epilepsy in patients aged 2-25 years

    Not recruiting

    4 1 1
    Investigated Drugs:
    Italy Romania Slovakia Spain
  • Study of Temocillin and Meropenem for Patients with Infections Caused by Resistant Enterobacteriaceae

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Spain
  • Study on Ibrutinib, CD20 Ab and Venetoclax for Patients with Untreated Mantle Cell Lymphoma

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Belgium France
  • Study of Nacystelyn for Patients with Obstructive Sleep Apnea

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France
  • Study of Tisagenlecleucel for Adults with Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma

    Not recruiting

    3 1 1 1
    Austria France Germany Italy The Netherlands Norway +1
  • Study of MK-4280A (Favezelimab and Pembrolizumab) for Patients with Metastatic Colorectal Cancer After Previous Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    France Italy Norway Spain
  • Study on Irinotecan, Fluorouracil, Oxaliplatin, and Calcium Folinate for Patients with Resectable Stomach and Gastroesophageal Junction Cancer

    Not recruiting

    2 1 1 1
    Norway Sweden

powered by